Scholar Rock Holding Total Assets 2017-2021 | SRRK

Scholar Rock Holding total assets from 2017 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Scholar Rock Holding Annual Total Assets
(Millions of US $)
2020 $388
2019 $196
2018 $181
2017 $62
2016 $33
Scholar Rock Holding Quarterly Total Assets
(Millions of US $)
2021-09-30 $298
2021-06-30 $332
2021-03-31 $361
2020-12-31 $388
2020-09-30 $163
2020-06-30 $156
2020-03-31 $176
2019-12-31 $196
2019-09-30 $189
2019-06-30 $197
2019-03-31 $171
2018-12-31 $181
2018-09-30 $109
2018-06-30 $119
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2016-12-31 $33
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.710B $0.015B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69